Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics Tests (PSICOM)
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of the study was to analyze the psychological and emotional determinants of domestic dissemination of information about genetic risk of cancer and to compare the level of diffusion syndromes in breast/ ovarian cancer ( BRCA1 / BRCA2) and colon/endometrial ( HNPCC )
Full description
The risk associated with a genetic predisposition is among the various forms of risk, the strongest identifiable risk . It enables to offer people at risk an appropriate medical care (screening, prevention ) the clinical benefit is validated today. The person with whom a predisposing mutation has been identified must communicated its related information on the risk of cancer and the ability to perform genetic analysis. It appears that this dissemination of information is not always optimal, as shown in figures from the National Cancer Institute joined the project; the purpose of the study was to analyze the psychological and emotional determinants of domestic dissemination of information about genetic risk of cancer and to compare the level of diffusion syndromes in breast/ ovarian cancer ( BRCA1 / BRCA2) and colon/endometrial ( HNPCC )
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patient having a deleterious genetic mutation on genes BRCA1 and/or BRCA2 and or on genes MMR
- The patient being of the family (who carried out a full analysis of BRCA1/BRCA2 and/or those MMR )
Exclusion criteria
- Patient not carrying a deleterious genetic mutation on the BRCA1/2 genes and/or those of the MMR system,
- Patient under guardianship, curator or unable to give his non-opposition,
- Adult patients protected by law.
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal